glucagon has been researched along with Diarrheogenic Islet Cell Tumor in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batcher, E; Gianoukakis, AG; Madaj, P | 1 |
| Hodin, RA; Stephen, AE | 1 |
| Thompson, JC; Townsend, CM | 1 |
| Bloom, SR; Williams, SJ; Wynick, D | 1 |
3 review(s) available for glucagon and Diarrheogenic Islet Cell Tumor
| Article | Year |
|---|---|
Pancreatic neuroendocrine tumors.
Topics: Gastrinoma; Gastrins; Glucagon; Glucagonoma; Hormones; Humans; Hypoglycemia; Insulinoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Somatostatinoma; Vasoactive Intestinal Peptide; Vipoma | 2011 |
Neuroendocrine tumors of the pancreas, excluding gastrinoma.
Topics: Carcinoma, Neuroendocrine; Glucagon; Humans; Liver Neoplasms; Liver Transplantation; Pancreatic Neoplasms; Somatostatin; Somatostatinoma; Tomography, X-Ray Computed; Vipoma | 2006 |
The clinical use of gastrointestinal hormones for alimentary tract disease.
Topics: Adenoma, Islet Cell; Cholecystokinin; Digestive System Diseases; Gastrointestinal Hormones; Glucagon; Glucagonoma; Humans; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatin; Somatostatinoma; Vipoma; Zollinger-Ellison Syndrome | 1996 |
1 other study(ies) available for glucagon and Diarrheogenic Islet Cell Tumor
| Article | Year |
|---|---|
Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors.
Topics: Adenoma, Islet Cell; Adult; Aged; Gastrins; Gastrointestinal Hemorrhage; Glucagon; Glucagonoma; Hormones; Humans; Insulinoma; Middle Aged; Pancreatic Neoplasms; Time Factors; Vasoactive Intestinal Peptide; Vipoma; Zollinger-Ellison Syndrome | 1988 |